Research output per year
Research output per year
Project Details
Description
Anti-tumor vaccination requires the identification of target antigens on resistant tumor subpopulations, adequate immune competence of the patients and the availability of efficient vaccination techniques.
| Acronym | SRP48 |
|---|---|
| Status | Active |
| Effective start/end date | 1/11/17 → 31/10/22 |
Flemish discipline codes
- Cancer therapy
Keywords
- Dendritic Cells
- Tonic Pain
- Evoked Potentials
- Bispecific Antibodies
- Immunotherapy
- Immunology
- Oncology
-
A distinct metabolic response characterizes sensitivity to EZH2 inhibition in multiple myeloma
Nylund, P., Atienza Párraga, A., Haglöf, J., De Bruyne, E., Menu, E., Garrido-Zabala, B., Ma, A., Jin, J., Öberg, F., Vanderkerken, K., Kalushkova, A. & Jernberg-Wiklund, H., 12 Feb 2021, In : Cell & Death Disease. 12, 2, 16 p., 167.Research output: Contribution to journal › Article
Open AccessFile4 Citations (Scopus)80 Downloads (Pure) -
Combining dual G9a/DNMTs epigenetic inhibition and immunotherapy to treat metastatic melanoma
De Beck, L., Awad, R. M., De Vlaeminck, Y., Basso, V., Casares, N., Verhulst, S., San José-Enériz, E., De Ridder, K., Goyvaerts, C., Maes, K., Vanderkerken, K., Agirre, X., Prosper, F., Lasarte, J. J., Mondino, A. & Breckpot, K., 11 Feb 2021, p. 1. 1 p.Research output: Unpublished contribution to conference › Unpublished abstract
Open AccessFile2 Downloads (Pure) -
CS1-specific single-domain antibodies labeled with Actinium-225 prolong survival and increase CD8+ T cells and PD-L1 expression in Multiple Myeloma
De Veirman, K., Puttemans, J., Krasniqi, A., Ertveldt, T., Hanssens, H., Romao, E., Hose, D., Goyvaert, C., Vlummens, P., Muyldermans, S., Breckpot, K., Bruchertseifer, F., Morgenstern, A., D'Huyvetter, M. & Devoogdt, N., 2021, In : Oncoimmunology. 10, 1, 11 p., 2000699.Research output: Contribution to journal › Article
Open Access
Projects
- 1 Finished
-
SRP14: SRP (Zwaartepunt): Targeting residual cancer cells: myeloma and melanoma as model diseases
Thielemans, K. & Vanderkerken, K.
1/11/12 → 31/10/17
Project: Fundamental
Activities
- 1 Talk or presentation at a workshop/seminar
-
Noninvasive imaging and inhibition of human programmed death ligand 1 using nanobody K2 to improve cancer immunotherapy
Karine Breckpot (Speaker)15 Nov 2021Activity: Talk or presentation › Talk or presentation at a workshop/seminar